次世代エネルギー産業・グリーン経済の国際リサーチ情報サイト

動物用ワクチンの世界市場:2025年に至る動物別、疾病別予測

Veterinary Vaccines Market by Disease (Swine Pneumonia, Avian Influenza, Rabies, Coccidiosis, Brucellosis, Canine Distemper), Type (Poultry, Livestock, Aquaculture, Porcine, Canine), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2025

出版元:MarketsandMarketsLinkIcon出版元について
発行年:2020年 5月
定価 Single User License(1名様ライセンス)US$5,650(米国ドル)/Multi User License(5名様)$6,650 /Corporate User License $8,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文 181ページになります。
商品コード:MAM1988

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。



【レポート紹介】
動物用ワクチンの世界市場規模は2020年段階で80億ドルと推計されます。同市場規模は2020年から2025年にかけて平均年成長率7.2%の増加で推移し、2025年には113億ドルに達するとレポートでは予測しています。当レポートでは、2025年に至る動物用ワクチンの世界市場予測(市場規模US$)、動物タイプ別市場(豚用ワクチン、家禽用ワクチン、家畜用ワクチン各種、コンパニオンアニマル用ワクチン各種、水産養殖用ワクチン、その他)、疾病別市場(豚各種、家禽各種、家畜各種、コンパニオンアニマル各種、水産養殖各種)、技術別市場(弱毒性ワクチン、不活化ワクチン、トキソイドワクチン、組み換えワクチン、その他)、主要国地域別市場など、各種の予測データに基づき市場を展望しています。また市場動向、競合状況、主要企業プロフィールなどの分析も交えて、概略以下の構成でお届けいたします。

【レポート構成概要】
◆動物用ワクチンの世界市場予測2018-2025年
・市場規模(US$)

◆動物タイプ別、市場-2025年
豚用ワクチン
家禽用ワクチン
家畜用ワクチン
・牛用ワクチン
・小型反芻動物ワクチン
コンパニオンアニマル用ワクチン
・犬用ワクチン
・猫用ワクチン
水産養殖用ワクチン
その他動物ワクチン
※(市場規模US$)

◆疾病別、市場-2025年
豚用ワクチン
・豚サーコウイルス2型(PCV2)
・豚繁殖-呼吸障害症候群(PRRS)
・豚パルボウイルス感染症
・豚インフルエンザ

家禽用ワクチン
・鶏伝染性気管支炎
・鳥インフルエンザ
・ニューカッスル病
・コクシジウム症

家畜用ワクチン
・牛用ワクチン
-口蹄疫
-牛ウイルス性下痢感染症
-牛クロストリジウム感染症
-ブルセラ症
-牛伝染性鼻気管炎
・小型反芻動物ワクチン
-小型反芻動物クロストリジウム感染症
-口感染症
-肺炎/敗血症
-ポックス感染症
-羊ヨーネ病
-その他

コンパニオンアニマル用ワクチン
・犬用ワクチン
-犬狂犬病
-犬ジステンパー
-犬パルボウイルス
-その他
・猫用ワクチン
-猫狂犬病
-猫ウイルス性鼻気管炎
-猫汎白血球減少症
-その他

水産養殖用ワクチン
-ビブリオ症
-パスツレラ症
-フルンケル
-その他
※(市場規模US$)

◆技術別、市場-2025年
・弱毒性ワクチン
・不活化ワクチン
・トキソイドワクチン
・組み換えワクチン
・その他ワクチン
※(市場規模US$)

◆主要国地域別市場-2025年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド、タイ
・その他アジア太平洋
その他地域
※国地域別に動物タイプ別、疾病別(豚、家禽、牛用)、技術別の細分化データ掲載、詳細は目次参照

◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会、課題)
・競合状況

◆動物用ワクチンの主要企業プロフィール動向
・ZOETIS
・MERCK ANIMAL HEALTH
・BOEHRINGER INGELHEIM
・ELANCO
・CEVA
・VIRBAC
・VETOQUINOL
・PHIBRO ANIMAL HEALTH
・HESTER BIOSCIENCES
・HIPRA
・BIOGENESIS BAGO
・TIANJIN RINGPU
・CHINA ANIMAL HUSBANDRY
・JINYU BIO-TECHNOLOGY

(その他企業)
・ENDOVAC ANIMAL HEALTH
・BRILLIANT BIO PHARMA PRIVATE LIMITED
・APTIMMUNE BIOLOGICS
・INDIAN IMMUNOLOGICALS LTD.
・TORIGEN
・VEROVACCINES
(全181頁)


【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

英文詳細目次(table of contents)

【原文詳細目次】

Veterinary Vaccines Market by Disease (Swine Pneumonia, Avian Influenza, Rabies, Coccidiosis, Brucellosis, Canine Distemper), Type (Poultry, Livestock, Aquaculture, Porcine, Canine), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2025

Table of Contents

1.... INTRODUCTION

1.1            OBJECTIVES OF THE STUDY
1.2            MARKET DEFINITION
1.3            MARKET SCOPE
1.3.1             MARKETS COVERED
1.3.2             YEARS CONSIDERED FOR THE STUDY
1.4            CURRENCY
1.5            LIMITATIONS
1.6            STAKEHOLDERS

2.... RESEARCH METHODOLOGY

2.1            RESEARCH DATA
2.1.1             SECONDARY DATA
2.1.1.1           KEY DATA FROM SECONDARY SOURCES
2.1.2             PRIMARY DATA
2.1.2.1           BREAKDOWN OF PRIMARY INTERVIEWS
2.2            MARKET SIZE ESTIMATION
2.2.1             BOTTOM-UP APPROACH
2.2.2             TOP-DOWN APPROACH. 27
2.2.3             GROWTH FORECAST. 27
2.3            MARKET BREAKDOWN AND DATA TRIANGULATION
2.4            ASSUMPTIONS FOR THE STUDY

3.... EXECUTIVE SUMMARY

4.... PREMIUM INSIGHTS

4.1            VETERINARY VACCINES MARKET OVERVIEW
4.2            NORTH AMERICA: VETERINARY VACCINES MARKET, BY TECHNOLOGY (2019)
4.3            SHARES OF MAJOR REGIONAL SEGMENTS IN THE VETERINARY VACCINES MARKET

5.... MARKET OVERVIEW

5.1            INTRODUCTION
5.2            MARKET DYNAMICS
5.2.1             DRIVERS
5.2.1.1           GROWTH IN THE COMPANION ANIMAL POPULATION
5.2.1.2           RISING INCIDENCE OF ZOONOTIC DISEASES
5.2.1.3           INITIATIVES BY VARIOUS GOVERNMENT AGENCIES AND ANIMAL ASSOCIATIONS. 38
5.2.1.4           RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS

5.2.2             RESTRAINTS
5.2.2.1           HIGH STORAGE COST OF VACCINES
5.2.3             OPPORTUNITIES
5.2.3.1           TECHNOLOGICAL ADVANCEMENTS
5.2.4             CHALLENGES
5.2.4.1           INADEQUATE SURVEILLANCE AND REPORTING SYSTEMS

6.... VETERINARY VACCINES MARKET, BY TYPE

6.1            INTRODUCTION
6.2            PORCINE VACCINES
6.2.1             PORCINE VACCINES SEGMENT DOMINATED THE MARKET IN 2019. 42
6.3            POULTRY VACCINES
6.3.1             INCREASED PRODUCTION AND REARING OF POULTRY TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
6.4            LIVESTOCK VACCINES. 45
6.4.1             BOVINE VACCINES
6.4.1.1           BOVINE VACCINES SEGMENT DOMINATED THE LIVESTOCK VACCINES MARKET IN 2019
6.4.2             SMALL RUMINANT VACCINES
6.4.2.1           CLOSTRIDIAL DISEASES AND SCABBY MOUTH INFECTION ARE SOME OF THE MAJOR DISEASES AFFECTING SMALL RUMINANTS
6.5            COMPANION ANIMAL VACCINES
6.5.1             CANINE VACCINES
6.5.1.1           CANINE VACCINES SEGMENT DOMINATED THE COMPANION ANIMAL VACCINES MARKET IN 2019
6.5.2             FELINE VACCINES
6.5.2.1           RISING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE THE DEMAND FOR FELINE VACCINES
6.6            AQUACULTURE VACCINES. 54
6.6.1             VACCINATION PLAYS A CRUCIAL ROLE IN COMMERCIAL FISH FARMING
6.7            OTHER ANIMAL VACCINES

7.... VETERINARY VACCINES MARKET, BY DISEASE

7.1            INTRODUCTION
7.2            PORCINE DISEASES
7.3            POULTRY DISEASES
7.4            LIVESTOCK DISEASES. 71
7.4.1             BOVINE DISEASES
7.4.2             SMALL RUMINANT DISEASES
7.5            COMPANION ANIMAL DISEASES
7.5.1             CANINE DISEASES
7.5.2             FELINE DISEASES
7.6            AQUACULTURE DISEASES. 74

8.... VETERINARY VACCINES MARKET, BY TECHNOLOGY

8.1            INTRODUCTION
8.2            LIVE ATTENUATED VACCINES
8.2.1             LIVE ATTENUATED VACCINES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2019
8.3            INACTIVATED VACCINES. 79
8.3.1             RISING NEED TO DEVELOP ARTIFICIAL IMMUNITY AGAINST DISEASES FROM NON-LIVING PATHOGENS IS A KEY FACTOR DRIVING THE GROWTH OF THE INACTIVATED VACCINES MARKET
8.4            TOXOID VACCINES
8.4.1             TOXOID VACCINES ARE USED WHEN A BACTERIAL TOXIN CAUSES AN ILLNESS
8.5            RECOMBINANT VACCINES. 82
8.5.1             ADVANTAGES ASSOCIATED WITH RECOMBINANT VACCINES DRIVING THEIR DEMAND
8.6            OTHER VACCINES

9.... VETERINARY VACCINES MARKET, BY REGION

9.1            INTRODUCTION
9.2            NORTH AMERICA
9.2.1             US
9.2.1.1           US IS THE LARGEST MARKET FOR VETERINARY VACCINES IN NORTH AMERICA
9.2.2             CANADA
9.2.2.1           RISING PET AND LIVESTOCK POPULATIONS IN CANADA TO SUPPORT MARKET GROWTH
9.3            EUROPE
9.3.1             GERMANY
9.3.1.1           GERMANY DOMINATED THE EUROPEAN VETERINARY VACCINES MARKET IN 2019
9.3.2             UK
9.3.2.1           GROWING PET ADOPTION IS INCREASING THE DEMAND FOR VETERINARY VACCINES IN THE UK
9.3.3             FRANCE
9.3.3.1           RISING PET OWNERSHIP TO SUPPORT MARKET GROWTH IN FRANCE
9.3.4             ITALY
9.3.4.1           INCREASING OUTBREAKS OF DISEASES TO SUPPORT MARKET GROWTH IN ITALY
9.3.5             SPAIN
9.3.5.1           INCREASE IN THE NUMBER OF VETERINARY PRACTICES AND THE WILLINGNESS TO SPEND ON ANIMAL HEALTHCARE TO DRIVE MARKET GROWTH IN SPAIN
9.3.6             REST OF EUROPE
9.4            ASIA PACIFIC
9.4.1             CHINA
9.4.1.1           OUTBREAK OF COVID-19 TO AFFECT THE OVERALL COMPANION ANIMAL MARKET IN CHINA
9.4.2             JAPAN
9.4.2.1           INCREASING EXPENDITURE ON PET HEALTHCARE TO DRIVE MARKET GROWTH IN JAPAN
9.4.3             INDIA
9.4.3.1        DEARTH OF VETERINARIANS TO RESTRAIN MARKET GROWTH IN INDIA
9.4.4             THAILAND
9.4.4.1           THAILAND IS A MAJOR MARKET FOR PORCINE VACCINES IN THE ASIA PACIFIC
9.4.5             REST OF APAC
9.5            REST OF THE WORLD

10.. COMPETITIVE LANDSCAPE

10.1          OVERVIEW
10.2          MARKET RANKING ANALYSIS
10.3          COMPETITIVE SCENARIO
10.4          COMPETITIVE LEADERSHIP MAPPING, 2019
10.4.1           VISIONARY LEADERS
10.4.2           INNOVATORS
10.4.3           DYNAMIC DIFFERENTIATORS
10.4.4           EMERGING COMPANIES

11.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, COMPETITIVE ANALYSIS)*
11.1          ZOETIS
11.2          MERCK ANIMAL HEALTH
11.3          BOEHRINGER INGELHEIM
11.4          ELANCO
11.5          CEVA
11.6          VIRBAC
11.7          VETOQUINOL
11.8          PHIBRO ANIMAL HEALTH
11.9          HESTER BIOSCIENCES
11.10        HIPRA
11.11        BIOGENESIS BAGO
11.12        TIANJIN RINGPU
11.13        CHINA ANIMAL HUSBANDRY
11.14        JINYU BIO-TECHNOLOGY
11.15        OTHER COMPANIES
11.15.1         ENDOVAC ANIMAL HEALTH
11.15.2         BRILLIANT BIO PHARMA PRIVATE LIMITED
11.15.3         APTIMMUNE BIOLOGICS
11.15.4         INDIAN IMMUNOLOGICALS LTD. 172
11.15.5         TORIGEN
11.15.6         VEROVACCINES
* BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, COMPETITIVE ANALYSIS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

12.. APPENDIX

LIST OF TABLES

TABLE 1              PERCENTAGE OF PET OWNERSHIP, BY REGION, 2017
TABLE 2              SMALL COMPANION ANIMAL POPULATION, BY COUNTRY, 2014 VS.
2016 VS. 2018 (MILLION)
TABLE 3              PAST AND PROJECTED TRENDS IN THE CONSUMPTION PATTERN OF MEAT AND MILK IN DEVELOPED AND DEVELOPING COUNTRIES
TABLE 4              VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 5              PORCINE VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 6              NORTH AMERICA: PORCINE VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 7              EUROPE: PORCINE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 8              ASIA PACIFIC: PORCINE VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 9              POULTRY VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 10            NORTH AMERICA: POULTRY VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 11            EUROPE: POULTRY VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 12            ASIA PACIFIC: POULTRY VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 13            LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 14            LIVESTOCK VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 15            NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 16            EUROPE: LIVESTOCK VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 17            ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 18            BOVINE VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 19            NORTH AMERICA: BOVINE VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 20            EUROPE: BOVINE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 21            ASIA PACIFIC: BOVINE VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 22            SMALL RUMINANT VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 23            NORTH AMERICA: SMALL RUMINANT VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 24            EUROPE: SMALL RUMINANT VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 25            ASIA PACIFIC: SMALL RUMINANT VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 26            COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 27            COMPANION ANIMAL VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 28            NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 29            EUROPE: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 30            ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 31            CANINE VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 32            NORTH AMERICA: CANINE VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 33            EUROPE: CANINE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34            ASIA PACIFIC: CANINE VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 35            FELINE VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 36            NORTH AMERICA: FELINE VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 37            EUROPE: FELINE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 38            ASIA PACIFIC: FELINE VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 39            AQUACULTURE VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 40            NORTH AMERICA: AQUACULTURE VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 41            EUROPE: AQUACULTURE VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 42            ASIA PACIFIC: AQUACULTURE VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 43            OTHER ANIMAL VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 44            NORTH AMERICA: OTHER ANIMAL VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 45            EUROPE: OTHER ANIMAL VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 46            ASIA PACIFIC: OTHER ANIMAL VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 47            PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 48            PORCINE CIRCOVIRUS II VACCINES MARKET, BY REGION,
2018–2025 (USD MILLION)
TABLE 49            NORTH AMERICA: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 50            EUROPE: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 51            ASIA PACIFIC: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 52            PRRS VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 53            NORTH AMERICA: PRRS VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 54            EUROPE: PRRS VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 55            ASIA PACIFIC: PRRS VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 56            PORCINE PARVOVIRUS VACCINES MARKET, BY REGION,
2018–2025 (USD MILLION)
TABLE 57            NORTH AMERICA: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 58            EUROPE: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 59            ASIA PACIFIC: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 60            SWINE INFLUENZA VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 61            NORTH AMERICA: SWINE INFLUENZA VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 62            EUROPE: SWINE INFLUENZA VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 63            ASIA PACIFIC: SWINE INFLUENZA VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 64            POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 65            INFECTIOUS BRONCHITIS VACCINES MARKET, BY REGION,
2018–2025 (USD MILLION)
TABLE 66            NORTH AMERICA: INFECTIOUS BRONCHITIS VACCINES MARKET,
BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 67            EUROPE: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 68            ASIA PACIFIC: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 69            AVIAN INFLUENZA VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 70            NORTH AMERICA: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 71            EUROPE: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 72            ASIA PACIFIC: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 73            NEWCASTLE DISEASE VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 74            NORTH AMERICA: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 75            EUROPE: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 76            ASIA PACIFIC: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 77            COCCIDIOSIS VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 78            NORTH AMERICA: COCCIDIOSIS VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 79            EUROPE: COCCIDIOSIS VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 80            ASIA PACIFIC: COCCIDIOSIS VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 81            BOVINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 82            FOOT-AND-MOUTH DISEASE VACCINES MARKET, BY REGION,
2018–2025 (USD MILLION)
TABLE 83            BOVINE VIRAL DIARRHEA VACCINES MARKET, BY REGION,
2018–2025 (USD MILLION)
TABLE 84            BOVINE CLOSTRIDIAL DISEASES VACCINES MARKET, BY REGION,
2018–2025 (USD MILLION)
TABLE 85            BRUCELLOSIS VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 86            INFECTIOUS BOVINE RHINOTRACHEITIS VACCINES MARKET, BY REGION,
2018–2025 (USD MILLION)
TABLE 87            SMALL RUMINANT VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 88            CANINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 89            FELINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)

TABLE 90            AQUACULTURE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 91            VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 92            LIVE ATTENUATED VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 93            NORTH AMERICA: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 94            EUROPE: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 95            ASIA PACIFIC: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 96            INACTIVATED VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 97            NORTH AMERICA: INACTIVATED VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 98            EUROPE: INACTIVATED VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 99            ASIA PACIFIC: INACTIVATED VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 100          TOXOID VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 101          NORTH AMERICA: TOXOID VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 102          EUROPE: TOXOID VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 103          ASIA PACIFIC: TOXOID VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 104          RECOMBINANT VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 105          NORTH AMERICA: RECOMBINANT VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 106          EUROPE: RECOMBINANT VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 107          ASIA PACIFIC: RECOMBINANT VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 108          OTHER VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 109          NORTH AMERICA: OTHER VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 110          EUROPE: OTHER VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 111          ASIA PACIFIC: OTHER VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 112          VETERINARY VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 113          NORTH AMERICA: VETERINARY VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 114          NORTH AMERICA: VETERINARY VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 115          NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 116          NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 117          NORTH AMERICA: PORCINE VACCINES MARKET, BY DISEASE,
2018–2025 (USD MILLION)
TABLE 118          NORTH AMERICA: POULTRY VACCINES MARKET, BY DISEASE,
2018–2025 (USD MILLION)
TABLE 119          NORTH AMERICA: BOVINE VACCINES MARKET, BY DISEASE,
2018–2025 (USD MILLION)
TABLE 120          NORTH AMERICA: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 121          US: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122          US: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123          US: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 124          US: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 125          US: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 126          US: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 127          CANADA: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128          CANADA: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129          CANADA: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 130          CANADA: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 131          CANADA: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 132          CANADA: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 133          EUROPE: NUMBER OF VETERINARIANS, BY COUNTRY, 2013–2017
TABLE 134          EUROPE: VETERINARY VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 135          EUROPE: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 136          EUROPE: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 137          EUROPE: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 138          EUROPE: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 139          EUROPE: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 140          EUROPE: BOVINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 141          EUROPE: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 142          GERMANY: COMPANION ANIMAL POPULATION, 2010–2018 (MILLION)
TABLE 143          GERMANY: DISEASE OUTBREAKS IN 2018
TABLE 144          GERMANY: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 145          GERMANY: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 146          GERMANY: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 147          GERMANY: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 148          GERMANY: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 149          GERMANY: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 150          UK: COMPANION ANIMAL POPULATION, 2010–2018 (MILLION)
TABLE 151          UK: ANIMAL DISEASE OUTBREAKS IN 2018
TABLE 152          UK: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 153          UK: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 154          UK: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 155          UK: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 156          UK: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 157          UK: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 158          FRANCE: ANIMAL DISEASE OUTBREAKS IN 2018
TABLE 159          FRANCE: NUMBER OF VETERINARIANS, 2014 VS. 2016 VS. 2018
TABLE 160          FRANCE: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 161          FRANCE: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 162          FRANCE: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 163          FRANCE: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 164          FRANCE: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 165          FRANCE: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 166          ITALY: COMPANION ANIMAL POPULATION, 2010–2018 (MILLION)
TABLE 167          ITALY: NUMBER OF VETERINARIANS, 2012 VS. 2018
TABLE 168          ITALY: ANIMAL DISEASE OUTBREAKS IN 2018
TABLE 169          ITALY: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 170          ITALY: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 171          ITALY: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 172          ITALY: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 173          ITALY: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 174          ITALY: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 175          SPAIN: ANIMAL DISEASE OUTBREAKS IN 2018
TABLE 176          SPAIN: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 177          SPAIN: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 178          SPAIN: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 179          SPAIN: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 180          SPAIN: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 181          SPAIN: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 182          REST OF EUROPE: VETERINARY VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 183          REST OF EUROPE: LIVESTOCK VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 184          REST OF EUROPE: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 185          REST OF EUROPE: PORCINE VACCINES MARKET, BY DISEASE,
2018–2025 (USD MILLION)
TABLE 186          REST OF EUROPE: POULTRY VACCINES MARKET, BY DISEASE,
2018–2025 (USD MILLION)
TABLE 187          REST OF EUROPE: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 188          ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 189          ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 190          ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 191          ASIA PACIFIC: PORCINE VACCINES MARKET, BY DISEASE,
2018–2025 (USD MILLION)
TABLE 192          ASIA PACIFIC: POULTRY VACCINES MARKET, BY DISEASE,
2018–2025 (USD MILLION)
TABLE 193          ASIA PACIFIC: BOVINE VACCINES MARKET, BY DISEASE,
2018–2025 (USD MILLION)
TABLE 194          ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 195          ASIA PACIFIC: VETERINARY VACCINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 196          CHINA: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 197          CHINA: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 198          CHINA: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 199          CHINA: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 200          CHINA: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 201          CHINA: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 202          PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS IN JAPAN (2000 VS. 2030) (THOUSAND METRIC TONS)
TABLE 203          JAPAN: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 204          JAPAN: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 205          JAPAN: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 206          JAPAN: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 207          JAPAN: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 208          JAPAN: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 209          PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS IN INDIA (2000 VS. 2030) (THOUSAND METRIC TONS)
TABLE 210          INDIA: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 211          INDIA: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 212          INDIA: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 213          INDIA: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 214          INDIA: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 215          INDIA: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 216          THAILAND: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 217          THAILAND: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 218          THAILAND: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 219          THAILAND: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 220          THAILAND: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 221          THAILAND: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 222          ROAPAC: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 223          ROAPAC: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 224          ROAPAC: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 225          ROAPAC: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 226          ROAPAC: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 227          ROAPAC: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 228          ROW: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 229          ROW: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 230          ROW: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 231          ROW: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 232          ROW: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 233          ROW: BOVINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 234          ROW: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 235          RANK OF COMPANIES IN THE VETERINARY VACCINES MARKET, 2019
TABLE 236          AGREEMENTS, PARTNERSHIPS, AND JOINT VENTURES (2017–2020)
TABLE 237          ACQUISITIONS (2017–2019)
TABLE 238          EXPANSIONS (2017–2020)


LIST OF FIGURES

FIGURE 1            RESEARCH DESIGN: VETERINARY VACCINES MARKET
FIGURE 2            BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION
FIGURE 3            MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 4            MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 5            DATA TRIANGULATION METHODOLOGY
FIGURE 6            VETERINARY VACCINES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 7            VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
FIGURE 8            PORCINE VACCINES MARKET, BY DISEASE, 2020 VS. 2025 (USD MILLION)
FIGURE 9            VETERINARY VACCINES MARKET: REGIONAL SNAPSHOT
FIGURE 10          GROWTH IN THE COMPANION ANIMAL POPULATION TO DRIVE MARKET GROWTH
FIGURE 11          LIVE ATTENUATED VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2019
FIGURE 12          NORTH AMERICA IS THE LARGEST REGIONAL MARKET FOR VETERINARY VACCINES
FIGURE 13          VETERINARY VACCINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14          NORTH AMERICA: VETERINARY VACCINES MARKET SNAPSHOT
FIGURE 15          ASIA PACIFIC: VETERINARY VACCINES MARKET SNAPSHOT
FIGURE 16          COMPETITIVE LEADERSHIP MAPPING (GLOBAL) VETERINARY VACCINES MARKET
FIGURE 17          ZOETIS: COMPANY SNAPSHOT (2019)
FIGURE 18          MERCK & CO., INC.: COMPANY SNAPSHOT (2019)
FIGURE 19          BOEHRINGER INGELHEIM: COMPANY SNAPSHOT (2019)
FIGURE 20          ELANCO: COMPANY SNAPSHOT (2019)
FIGURE 21          CEVA: COMPANY SNAPSHOT (2017)
FIGURE 22          VIRBAC: COMPANY SNAPSHOT (2018)
FIGURE 23          VETOQUINOL: COMPANY SNAPSHOT (2018)
FIGURE 24          PHIBRO ANIMAL HEALTH: COMPANY SNAPSHOT (2019)
FIGURE 25          HESTER BIOSCIENCES: COMPANY SNAPSHOT (2019)


掲載企業リスト

プレスリリース

プレスリリース

Memo.png当レポートのプレスリリースは発行されておりません。

資料検索

お探しの資料・レポートをキーワードで検索ください。

当サイト内の検索結果が表示されます。調査レポートは英文目次を掲載しているため、英語検索も有効です。
(ブラウザのスクリプトを有効にしないとサーチエンジンが表示されません)

お問い合わせ

2714110_0.jpg
レポートをお探しいたします。
当サイトに掲載されているレポート以外にも幅広くご提案可能です。レポートの内容に関するご質問、ご確認にも回答いたします。お気軽にお問い合わせください。